Cariporide, a specific Na/H+ exchanger 1 blocker, inhibits neointimal proliferation induced by advanced glycation end products in a balloon injury rat model

Pharmacology

Volumn 91, Issue 3-4, 2013, Pages 123-130

  Wu, Shujin ^a,b   Yang, Qingshan ^a   Liu, Qianqian ^c   Song, Tao ^b   Zhou, Shouhong ^b   Liu, Yuhui ^b   Liu, Liying ^b  

^a Gan Su Province Hospital   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c Western Medicine Hospital   (China)

Author keywords

Advanced glycation end products; Na+ H+ exchanger 1; Neointimal formation; Nuclear factor B; Oxidative stress

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CARIPORIDE; CYCLOOXYGENASE 2; FLUORESCENT DYE; GELATINASE A; GELATINASE B; GLUTATHIONE PEROXIDASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MALONALDEHYDE; MATRIX METALLOPROTEINASE; SODIUM PROTON EXCHANGE PROTEIN 1; SUPEROXIDE DISMUTASE; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BALLOON; BLOOD VESSEL INJURY; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HYPERPLASIA; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING; ANIMAL CELL; DRUG MECHANISM; EXPERIMENTAL BALLOON CATHETER INJURY; UPREGULATION;

ANGIOPLASTY, BALLOON; ANIMALS; AORTA, THORACIC; CAROTID ARTERY INJURIES; CELL PROLIFERATION; CYCLOOXYGENASE 2; GLYCOSYLATION END PRODUCTS, ADVANCED; GUANIDINES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MYOCYTES, SMOOTH MUSCLE; NEOINTIMA; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SODIUM-HYDROGEN ANTIPORTER; SULFONES;

EID: 84872768273     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000346128     Document Type: Article

References (24)

1. Choi EY, Kwon HM, Ahn CW, Lee GT, Joung B, Hong BK, Yoon YW, Kim D, Byun KH, Kang TS, Yoon SJ, Kwon SW, Lee SJ, Park JK, Kim HS: Serum levels of advanced glycation end products are associated with in-stent restenosis in diabetic patients. Yonsei Med J 2005; 28: 78-85
2. Naka Y, Bucciarelli LG, Wendt T, Lee LK, Rong LL, Ramasamy R, Yan SF, Schmidt AM: RAGE axis: animal models and novel insights into the vascular complications of diabetes. Arterioscler Thromb Vasc Biol 2004; 24: 1342-1349
3. Sakaguchi T, Yan SF, Yan SD, Belov D, Rong LL, Sousa M, Andrassy M, Marso SP, Duda S, Arnold B, Liliensiek B, Nawroth PP, Stern DM, Schmidt AM, Naka Y: Central role of RAGEdependent neointimal expansion in arterial restenosis. J Clin Invest 2003; 111: 959-972
4. Liu Y, Liang C, Liu X, Liao B, Pan X, Ren Y, Fan M, Li M, He Z, Wu J, Wu Z: AGEs increased migration and inflammatory responses of adventitial fibroblasts via RAGE, MAPK and NF-kappaB pathways. Atherosclerosis 2010; 208: 34-42
5. Kim JB, Song BW, Park S, Hwang KC, Cha BS, Jang Y, Lee HC, Lee MH: Alagebrium chloride, a novel advanced glycation end-product cross linkage breaker, inhibits neointimal proliferation in a diabetic rat carotid balloon injury model. Korean Circ J 2010; 40: 520-526
6. Park S, Yoon SJ, Tae HJ, Shim CY: RAGE and cardiovascular disease. Front Biosci 2011; 16: 486-497
7. Sarigianni M, Tsapas A, Mikhailidis DP, Kaloyianni M, Koliakos G, Fliegel L, Paletas K: Na+/H+ exchanger-1: a link with atherogenesis? Expert Opin Investig Drugs 2010; 19: 1545-1556
8. Reshkin SJ, Cardone RA, Harguindey S: Na + -H + exchanger, pH regulation and cancer. Recent Pat Anticancer Drug Discov 2012, E-pub ahead of print
9. De Vito P: The sodium/hydrogen exchanger: a possible mediator of immunity. Cell Immunol 2006; 240: 69-85
10. Sarigianni M, Tsapas A, Mikhailidis DP, Kaloyianni M, Koliakos G, Paletas K: Involvement of signaling molecules on Na/H exchanger-1 activity in human monocytes. Open Cardiovasc Med J 2010; 28: 181-188
11. Wu S, Song T, Zhou S, Liu Y, Chen G, Huang N, Liu L: Involvement of Na+/H+ exchanger in advanced glycation end products-induced proliferation of vascular smooth muscle cell. Biochem Biophys Res Commun 2008; 375: 384-389
12. Shuang-Xi W, Li-Ying L, Hu M, Yu-Hui L: Na+/H+ exchanger inhibitor prevented endothelial dysfunction induced by high glucose. J Cardiovasc Pharmacol 2005; 45: 586-590
13. Song T, Wu S, Liu L, Chen G, Liu L: Protective effect of cariporide on the endothelial impairment caused by advanced glycation end products in rats. Central South Pharmacy 2007; 5: 429-432
14. Siffert W, Dusing R: Na+/H+ exchange in hypertension and in diabetes mellitus - facts and hypotheses. Basic Res Cardiol 1996; 91: 179-190
15. Mitsuka M, Nagae M, Berk BC: Na(+)-H+ exchange inhibitors decrease neointimal formation after rat carotid injury. Effects on smooth muscle cell migration and proliferation. Circ Res1993; 73: 269-275
16. Yoon SJ, Yoon YW, Lee BK, Kwon HM, Hwang KC, Kim M, Chang W, Hong BK, Lee YH, Park SJ, Min PK, Rim SJ: Potential role of HMG CoA reductase inhibitor on oxidative stress induced by advanced glycation endproducts in vascular smooth muscle cells of diabetic vasculopathy. Exp Mol Med 2009; 41: 802-811
17. Fang XY, Li YG, Lin JJ, Zeng X: Na+-H+ exchanger protein changes in vascular smooth muscle and effect of Na+-H+ exchange inhibitor on vessel stenosis after balloon injuries in rabbits. Zhonghua Xin Xue Guan Bing Za Zhi 2005; 33: 1037-1042
18. Yi N, Chen SY, Ma A, Chen PS, Yao B, Liang TM, Liu C: Tunicamycin inhibits PDGF-BBinduced proliferation and migration of vascular smooth muscle cells through induction of HO-1. Anat Rec (Hoboken) 2012; 295: 1462-1472
19. Kwon JS, Joung H, Kim YS, Shim YS, Ahn Y, Jeong MH, Kee HJ: Sulforaphane inhibits restenosis by suppressing inflammation and the proliferation of vascular smooth muscle cells. Atherosclerosis 2012; 225: 41-49
20. Johnson C, Galis ZS: Matrix metalloproteinase-and -9 differentially regulate smooth muscle cell migration and cell-mediated collagen organization. Arterioscler Thromb Vasc Biol 2004; 24: 54-60
21. Cho A, Reidy MA: Matrix metalloproteinase-is necessary for the regulation of smooth muscle cell replication and migration after arterial injury. Circ Res 2002; 91: 845-851
22. Yang X, Wang D, Dong W, Song Z, Dou K: Inhibition of Na(+)/H(+) exchanger 1 by 5-(N-ethyl-N-isopropyl) amiloride reduces hypoxia-induced hepatocellular carcinoma invasion and motility. Cancer Lett 2010; 295: 198-204
23. Nemeth ZH, Deitch EA, Szabo C, Hasko G: NHE blockade inhibits chemokine production and NF-kB activation in immunostimulated endothelial cells. Am J Physiol Cell Physiol 2002; 283:C396-C403
24. Guo X, Wang L, Chen B, Li Q, Wang J, Zhao M, Wu W, Zhu P, Huang X, Huang Q: ERM protein moesin is phosphorylated by advanced glycation end products and modulates endothelial permeability. Am J Physiol Heart Circ Physiol 2009; 297: 238-246